Assignee
AVACTA LIFE SCIENCES LTD
GB·3 granted patents·8 pending applications·7 citations·filing 2014–2025
Top patents by PatentIndex Score
11 records- 0181US9447170B2Modified Stefin A scaffold proteinsAVACTA LIFE SCIENCES LTD·Filed 2014·Granted Sep 20, 2016·6 cites·14 claims
- 0276US12286468B2Scaffold proteinsAVACTA LIFE SCIENCES LTD·Filed 2024·Granted Apr 29, 2025·0 cites·19 claims
- 0371US11952415B2Scaffold proteinsAVACTA LIFE SCIENCES LTD·Filed 2018·Granted Apr 9, 2024·1 cites·32 claims
- 0464US2025270293A1Scaffold proteinsAVACTA LIFE SCIENCES LTD·Filed 2025·Application pending·0 cites
- 0548US2024409638A1Serum half-life extended pd-l1 binding polypeptidesAVACTA LIFE SCIENCES LTD·Filed 2022·Application pending·0 cites
- 0648US2025243277A1Pd-l1 binding affimersAVACTA LIFE SCIENCES LTD·Filed 2022·Application pending·0 cites
- 0747US2023390409A1Fap-activated serum extended half-life therapeutic conjugatesAVACTA LIFE SCIENCES LTD·Filed 2021·Application pending·0 cites
- 0847US2023381330A1Enzyme-activated serum extended half-life therapeutic conjugatesAVACTA LIFE SCIENCES LTD·Filed 2021·Application pending·0 cites
- 0943US2023272081A1Serum half-life extended pd-l1 inhibitory polypeptidesAVACTA LIFE SCIENCES LTD·Filed 2021·Application pending·0 cites
- 1041US2023272011A1Serum albumin-binding polypeptidesAVACTA LIFE SCIENCES LTD·Filed 2021·Application pending·0 cites
- 1129US2021163599A1Pd-l1 binding affimers, and uses related theretoAVACTA LIFE SCIENCES LTD·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →